RANK deletion in tumor cells, but not in myeloid cells, leads to an increase in immune, lymphocyte, and CD8+ T-lymphocyte infiltration, and a reduction in the infiltration of myeloid cells. The gene discussed is TNFRSF11A; the disease is neoplasm.